Cargando…

The Role of Palliative Care in Chronic Progressive Neurological Diseases—A Survey Amongst Neurologists in the Netherlands

Background: Chronic progressive neurological diseases like high grade glioma (HGG), Parkinson's disease (PD), and multiple sclerosis (MS) are incurable, and associated with increasing disability including cognitive impairment, and reduced life expectancy. Patients with these diseases have compl...

Descripción completa

Detalles Bibliográficos
Autores principales: Walter, Hannah A. W., Seeber, Antje A., Willems, Dick L., de Visser, Marianne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340288/
https://www.ncbi.nlm.nih.gov/pubmed/30692960
http://dx.doi.org/10.3389/fneur.2018.01157
_version_ 1783388771715121152
author Walter, Hannah A. W.
Seeber, Antje A.
Willems, Dick L.
de Visser, Marianne
author_facet Walter, Hannah A. W.
Seeber, Antje A.
Willems, Dick L.
de Visser, Marianne
author_sort Walter, Hannah A. W.
collection PubMed
description Background: Chronic progressive neurological diseases like high grade glioma (HGG), Parkinson's disease (PD), and multiple sclerosis (MS) are incurable, and associated with increasing disability including cognitive impairment, and reduced life expectancy. Patients with these diseases have complex care needs. Therefore, timely advance care planning (ACP) is required. Our aim was to investigate timing and content of discussions on treatment restrictions, i.e., to initiate, withhold, or withdraw treatment in patients with HGG, PD, and MS, from the neurologists' perspective. Methods: We performed a national online survey amongst consultants in neurology and residents in The Netherlands. The questionnaire focused on their daily practice concerning timing and content of discussions on treatment restrictions with patients suffering from HGG, PD or MS. We also inquired about education and training in discussing these issues. Results: A total of 125 respondents [89 neurologists (71%), 62% male, with a median age of 44 years, and 36 residents (29%), 31% male with a median age of 29 years] responded. Initial discussions on treatment restrictions were said to take place during the first year after diagnosis in 28% of patients with HGG, and commonly no earlier than in the terminal phase in patients with PD and MS. In all conditions, significant cognitive decline was the most important trigger to advance discussions, followed by physical decline, and initiation of the terminal phase. Most discussed issues included ventilation, resuscitation, and admission to the intensive care unit. More than half of the consultants in neurology and residents felt that they needed (more) education and training in having discussions on treatment restrictions. Conclusion: In patients with HGG discussions on treatment restrictions are initiated earlier than in patients with PD or MS. However, in all three diseases these discussions usually take place when significant physical and cognitive decline has become apparent and commonly mark the initiation of end-of-life care. More than half of the responding consultants in neurology and residents feel the need for improvement of their skills in performing these discussions.
format Online
Article
Text
id pubmed-6340288
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-63402882019-01-28 The Role of Palliative Care in Chronic Progressive Neurological Diseases—A Survey Amongst Neurologists in the Netherlands Walter, Hannah A. W. Seeber, Antje A. Willems, Dick L. de Visser, Marianne Front Neurol Neurology Background: Chronic progressive neurological diseases like high grade glioma (HGG), Parkinson's disease (PD), and multiple sclerosis (MS) are incurable, and associated with increasing disability including cognitive impairment, and reduced life expectancy. Patients with these diseases have complex care needs. Therefore, timely advance care planning (ACP) is required. Our aim was to investigate timing and content of discussions on treatment restrictions, i.e., to initiate, withhold, or withdraw treatment in patients with HGG, PD, and MS, from the neurologists' perspective. Methods: We performed a national online survey amongst consultants in neurology and residents in The Netherlands. The questionnaire focused on their daily practice concerning timing and content of discussions on treatment restrictions with patients suffering from HGG, PD or MS. We also inquired about education and training in discussing these issues. Results: A total of 125 respondents [89 neurologists (71%), 62% male, with a median age of 44 years, and 36 residents (29%), 31% male with a median age of 29 years] responded. Initial discussions on treatment restrictions were said to take place during the first year after diagnosis in 28% of patients with HGG, and commonly no earlier than in the terminal phase in patients with PD and MS. In all conditions, significant cognitive decline was the most important trigger to advance discussions, followed by physical decline, and initiation of the terminal phase. Most discussed issues included ventilation, resuscitation, and admission to the intensive care unit. More than half of the consultants in neurology and residents felt that they needed (more) education and training in having discussions on treatment restrictions. Conclusion: In patients with HGG discussions on treatment restrictions are initiated earlier than in patients with PD or MS. However, in all three diseases these discussions usually take place when significant physical and cognitive decline has become apparent and commonly mark the initiation of end-of-life care. More than half of the responding consultants in neurology and residents feel the need for improvement of their skills in performing these discussions. Frontiers Media S.A. 2019-01-14 /pmc/articles/PMC6340288/ /pubmed/30692960 http://dx.doi.org/10.3389/fneur.2018.01157 Text en Copyright © 2019 Walter, Seeber, Willems and de Visser. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Walter, Hannah A. W.
Seeber, Antje A.
Willems, Dick L.
de Visser, Marianne
The Role of Palliative Care in Chronic Progressive Neurological Diseases—A Survey Amongst Neurologists in the Netherlands
title The Role of Palliative Care in Chronic Progressive Neurological Diseases—A Survey Amongst Neurologists in the Netherlands
title_full The Role of Palliative Care in Chronic Progressive Neurological Diseases—A Survey Amongst Neurologists in the Netherlands
title_fullStr The Role of Palliative Care in Chronic Progressive Neurological Diseases—A Survey Amongst Neurologists in the Netherlands
title_full_unstemmed The Role of Palliative Care in Chronic Progressive Neurological Diseases—A Survey Amongst Neurologists in the Netherlands
title_short The Role of Palliative Care in Chronic Progressive Neurological Diseases—A Survey Amongst Neurologists in the Netherlands
title_sort role of palliative care in chronic progressive neurological diseases—a survey amongst neurologists in the netherlands
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6340288/
https://www.ncbi.nlm.nih.gov/pubmed/30692960
http://dx.doi.org/10.3389/fneur.2018.01157
work_keys_str_mv AT walterhannahaw theroleofpalliativecareinchronicprogressiveneurologicaldiseasesasurveyamongstneurologistsinthenetherlands
AT seeberantjea theroleofpalliativecareinchronicprogressiveneurologicaldiseasesasurveyamongstneurologistsinthenetherlands
AT willemsdickl theroleofpalliativecareinchronicprogressiveneurologicaldiseasesasurveyamongstneurologistsinthenetherlands
AT devissermarianne theroleofpalliativecareinchronicprogressiveneurologicaldiseasesasurveyamongstneurologistsinthenetherlands
AT walterhannahaw roleofpalliativecareinchronicprogressiveneurologicaldiseasesasurveyamongstneurologistsinthenetherlands
AT seeberantjea roleofpalliativecareinchronicprogressiveneurologicaldiseasesasurveyamongstneurologistsinthenetherlands
AT willemsdickl roleofpalliativecareinchronicprogressiveneurologicaldiseasesasurveyamongstneurologistsinthenetherlands
AT devissermarianne roleofpalliativecareinchronicprogressiveneurologicaldiseasesasurveyamongstneurologistsinthenetherlands